📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
40 announcements match the current filters (relevance ≥ 5).
Fabtech Technologies to Form 51% Step-Down Subsidiary in Saudi Arabia for Expansion
Fabtech Technologies Limited, through its wholly owned subsidiary Fabtech Technologies LLC, has entered into a shareholders agreement to incorporate a new entity in Saudi Arabia. The new company, Specialized Contracting Activities LLC, will be a step-down subsidiary with Fabtech's subsidiary holding a 51% stake. This venture marks a strategic entry into the Saudi Arabian market, focusing on specialized mechanical, electrical, plumbing, and civil contracting for non-pharmaceutical industries. The investment will be a 100% cash subscription at face value.
Key Highlights
Fabtech's subsidiary to hold a controlling 51% stake in the new Saudi Arabian entity.
The new company will focus on MEP and Civil contracting for non-pharma industries in KSA.
Partnership formed with Mr. Saleh Mousa Eidhah Al-Zahrani and Specialized Contracting Activities LLC.
Investment is structured as a 100% cash consideration at face value per share.
The move signifies geographical and sectoral diversification for Fabtech Technologies.
👀 What to Watch
Investors should view this as a positive growth move into the high-potential Saudi market; monitor for future project announcements and the impact on consolidated margins.
Fabtech Appoints New Independent Director and SVP; Announces Senior Management Retirements
Fabtech Technologies has announced a leadership transition, appointing Ms. Bharti Khanna as an Independent Director for a five-year term to strengthen board governance. The company also hired Mr. Ajaj Abdul Rahiman Kazi, a veteran with over 27 years of experience from Reliance and Voltas, as Senior Vice President to lead MEP projects. Concurrently, the company noted the retirement of two senior executives: the SVP of Operations and the AVP of Logistics. These changes reflect a mix of planned succession and strategic hiring to bolster technical and regulatory expertise.
Key Highlights
Appointment of Ms. Bharti Khanna as Independent Director for a 5-year term, bringing 30+ years of pharma R&D and regulatory experience.
Hiring of Mr. Ajaj Abdul Rahiman Kazi as SVP, who previously spent 23 years at Voltas and served as Head of MEP at Reliance Industries.
Retirement of Mr. Dilip Ghosh (SVP - Operations) and Mr. Ranganathan Gkseetharaman (AVP - Logistics) effective May 25, 2026.
Board approved a Postal Ballot to seek shareholder approval for the appointment of two Independent Directors.
The new SVP, Mr. Kazi, is a certified Project Management Professional (PMP) with extensive experience in large-scale infrastructure and industrial projects.
👀 What to Watch
Investors should monitor if the new Senior Vice President's extensive experience in MEP and project management leads to improved execution timelines for current projects. No immediate action is required as these are standard governance and succession updates.
Fabtech Appoints New Independent Director & Senior VP; Two Senior Executives Retire
Fabtech Technologies has announced a significant refresh of its leadership team effective May 25, 2026. The company appointed Ms. Bharti Khanna, a pharma veteran with 30+ years of experience, as an Independent Director for a 5-year term. Additionally, Mr. Ajaj Abdul Rahiman Kazi, who has 27+ years of experience in MEP project management from Reliance and Voltas, joins as Senior Vice President. These appointments coincide with the retirement of the SVP of Operations and the AVP of Logistics, marking a transition in senior management.
Key Highlights
Appointment of Ms. Bharti Khanna as Independent Director for a 5-year term starting May 25, 2026
New Senior VP Mr. Ajaj Abdul Rahiman Kazi brings 27+ years of experience in MEP and project management
Retirement of Mr. Dilip Ghosh (SVP Operations) and Mr. Ranganathan Gkseetharaman (AVP Logistics)
Ms. Bharti Khanna holds 30+ years of expertise in pharmaceutical R&D, regulatory affairs, and GMP compliance
👀 What to Watch
Investors should monitor the transition in operations and logistics following the retirements to ensure project execution remains steady. The addition of high-caliber professionals from the pharma and MEP sectors is a positive sign for long-term governance and operational scaling.
Fabtech Appoints New Independent Director and SVP; Announces Senior Management Retirements
Fabtech Technologies has announced a significant reshuffle in its leadership team, including the appointment of Ms. Bharti Khanna as an Independent Director for a 5-year term. The company also hired Mr. Ajaj Abdul Rahiman Kazi, a veteran with 27 years of experience from Reliance and Voltas, as Senior Vice President. These appointments coincide with the retirement of two senior executives: Mr. Dilip Ghosh (SVP - Operations) and Mr. Ranganathan Gkseetharaman (AVP - Logistics), effective May 25, 2026. The move appears to be a strategic effort to strengthen the board with pharmaceutical and MEP project management expertise.
Key Highlights
Ms. Bharti Khanna appointed as Independent Director for a 5-year term, bringing 30+ years of pharma R&D and regulatory experience.
Mr. Ajaj Abdul Rahiman Kazi joins as Senior VP with 27 years of experience in MEP project management from Reliance Industries and Voltas.
Retirement of SVP - Operations and AVP - Logistics effective from the closure of business hours on May 25, 2026.
Company seeking shareholder approval via postal ballot for the appointment of two Independent Directors.
👀 What to Watch
Investors should monitor the transition in operations and logistics following the retirement of key personnel, while the addition of a pharma-specialist director and an experienced MEP lead is a positive sign for future project execution.
Fabtech Appoints New Independent Directors and Senior VP; Two Senior Executives Retire
Fabtech Technologies has announced a leadership transition, appointing Ms. Bharti Khanna as an Independent Director for a five-year term and Mr. Ajaj Abdul Rahiman Kazi as Senior Vice President. Mr. Kazi brings over 27 years of experience from major firms like Reliance Industries and Voltas, specializing in project management. Simultaneously, the company announced the retirement of two senior officials, Mr. Dilip Ghosh (SVP - Operations) and Mr. Ranganathan Gkseetharaman (AVP - Logistics), effective May 25, 2026. These moves reflect a strategic effort to infuse fresh expertise into the board and senior management while managing natural retirements.
Key Highlights
Ms. Bharti Khanna appointed as Independent Director for 5 years with 30+ years of pharmaceutical R&D and regulatory experience.
Mr. Ajaj Abdul Rahiman Kazi appointed as SVP with 27+ years of experience in MEP project management from Reliance and Voltas.
Retirement of SVP Operations and AVP Logistics effective from the closure of business hours on May 25, 2026.
Board approved a Postal Ballot to seek shareholder approval for the appointment of two Independent Directors.
👀 What to Watch
Investors should monitor how the new leadership, particularly the new SVP with large-cap experience, impacts operational efficiency. No immediate action is required as these appear to be planned transitions.
Fabtech Technologies Appoints New Independent Director and SVP; Announces SMP Retirements
Fabtech Technologies has announced a significant leadership transition, appointing Ms. Bharti Khanna as an Independent Director for a five-year term to leverage her 30 years of pharmaceutical industry expertise. The company also hired Mr. Ajaj Abdul Rahiman Kazi, a veteran with 27 years of experience from Reliance and Voltas, as Senior Vice President to lead MEP projects. These appointments coincide with the retirement of two senior management personnel: the SVP of Operations and the AVP of Logistics. This reshuffle indicates a strategic effort to refresh senior leadership while maintaining industry-specific technical depth.
Key Highlights
Ms. Bharti Khanna appointed as Independent Director for a 5-year term, bringing 30+ years of pharma R&D and regulatory experience.
Mr. Ajaj Abdul Rahiman Kazi joins as Senior Vice President with 27+ years of MEP project management experience from Reliance and Voltas.
Retirement of Mr. Dilip Ghosh (SVP - Operations) and Mr. Ranganathan Gkseetharaman (AVP - Logistics) effective May 25, 2026.
Board approved a Postal Ballot to seek shareholder approval for the appointment of two Independent Directors.
👀 What to Watch
Investors should monitor the operational transition following the retirement of the SVP of Operations and observe if the new SVP's extensive experience at Reliance and Voltas improves project execution efficiency.
Fabtech FY26 Income Up 28% to ₹431 Cr; Order Book Surpasses ₹900 Cr
Fabtech Technologies reported a robust FY26 with total income growing 28.4% YoY to ₹431.33 crore and EBITDA rising 18.29% to ₹55.56 crore. While the reported PAT of ₹38.36 crore appears lower than FY25's ₹46.45 crore, the previous year included a ₹17.85 crore exceptional gain; operational net profit actually grew by approximately 18%. The company significantly strengthened its balance sheet via a ₹230 crore equity infusion, ending the year with a cash balance of ₹208.57 crore and a massive order book exceeding ₹900 crore. Management has guided for 25% growth in FY27 with PAT margins targeted between 9.9% and 10.5%.
Key Highlights
Total income for FY26 increased 28.4% YoY to ₹431.33 crore, with Q4 alone contributing ₹168.24 crore.
Order book stands at over ₹900 crore, providing strong revenue visibility for the next two years.
Strategic equity infusion of ₹230 crore boosted total equity to ₹419.77 crore and cash reserves to ₹208.57 crore.
Management projects 25% revenue growth for FY27 with an improved PAT margin target of 9.9% to 10.5%.
Receivables rose to ₹204.34 crore, which the company has identified as a key operational priority for collection-led discipline.
👀 What to Watch
Investors should view the strong order book and healthy cash position as positive indicators for future execution, though the rising receivables require monitoring. The shift toward high-value projects in Saudi Arabia and Africa suggests improving structural profitability for the long term.
Fabtech Technologies FY26 Income Grows 28% to ₹431 Cr; Order Book Exceeds ₹900 Cr
Fabtech Technologies reported a strong 28% YoY increase in total income to ₹431.33 crore for FY26, supported by a robust Q4 performance where income rose 22% to ₹168.24 crore. The company's order book has reached a significant milestone of over ₹900 crore, providing high revenue visibility for the coming years. While Q4 margins faced temporary pressure from external disruptions, the company maintained an EBITDA margin of 12.88% for the full year. A strategic equity infusion of ₹230 crore has significantly strengthened the balance sheet to fund global expansion in the life science infrastructure sector.
Key Highlights
FY26 Total Income increased 28% YoY to ₹431.33 Cr compared to ₹335.94 Cr in FY25.
Order book stands at over ₹900 Cr, representing more than 2x the current annual revenue.
Full-year PAT reached ₹38.36 Cr with an 8.89% margin, despite Q4 margin headwinds.
Successfully raised approximately ₹230 Cr through strategic equity infusion to fuel growth.
Management targets margin expansion to 9.9%–10.5% in FY27 through operating leverage.
👀 What to Watch
Investors should focus on the company's ability to execute its massive ₹900 Cr order book and the projected margin recovery in FY27. The strong balance sheet and expansion into GCC and African markets position the company well for long-term growth.
Fabtech FY26 Revenue Up 28% to ₹431 Cr; Order Book Surpasses ₹900 Cr
Fabtech Technologies reported a strong FY26 performance with total income growing 28.4% YoY to ₹431.33 crore and a net profit of ₹38.36 crore. The company's order book stands robust at over ₹900 crore, providing significant revenue visibility for the coming years. Geographically, the UAE and Saudi Arabia remain the largest contributors, while the Kenyan market saw a massive 236% surge in revenue. Notably, the company improved its cash flow position and reduced its debt, strengthening its balance sheet.
Key Highlights
Total Income grew 28.4% YoY to ₹431.33 crore, driven by international turnkey projects in the life sciences sector.
Consolidated order book reached ₹900+ crore as of March 31, 2026, providing strong revenue visibility.
Cash and bank balances increased significantly by 495.7% to ₹208.57 crore during the fiscal year.
Successfully reduced current borrowings from ₹54.09 crore to ₹42.20 crore, improving the debt-to-equity profile.
Major new project wins include a ₹65.5 crore animal vaccine project in Saudi Arabia and a ₹63.6 crore facility in West Africa.
👀 What to Watch
Investors should take note of the company's strong execution capabilities and growing presence in high-margin international markets. The significant reduction in debt and robust order book suggest a positive outlook for the next fiscal year.
Fabtech Technologies Reports Zero Deviation in Utilization of ₹230.30 Cr IPO Proceeds
Fabtech Technologies Limited has confirmed that there was no deviation or variation in the utilization of funds raised through its Initial Public Offering (IPO) for the quarter ended March 31, 2026. The company raised approximately ₹230.30 crore on October 7, 2025, to fund its stated business objectives. The Audit Committee reviewed the statement on April 27, 2026, and found no discrepancies in fund usage. This report, monitored by CRISIL Ratings, ensures that the capital is being deployed according to the original prospectus.
Key Highlights
Total IPO proceeds raised on October 7, 2025, amounted to ₹2,30,29,65,305 (approx. ₹230.30 crore).
The company reported zero deviation or variation in the utilization of funds for the quarter ended March 31, 2026.
CRISIL Ratings Limited is the appointed monitoring agency overseeing the fund utilization.
The Audit Committee reviewed and approved the statement in its meeting held on April 27, 2026.
👀 What to Watch
Investors should view this as a positive sign of corporate governance and adherence to the stated business plan. No immediate action is required as the company is deploying capital as promised.
Fabtech Technologies Recommends ₹0.60 Dividend and Announces Oman Expansion
Fabtech Technologies has recommended a final dividend of ₹0.60 per equity share for the financial year ended March 31, 2026. Alongside the dividend, the company approved its audited FY26 financial results and authorized the establishment of a new step-down subsidiary in the Sultanate of Oman. The company's foreign subsidiary showed strong performance, contributing ₹17,378.57 Lakhs in revenue and ₹1,274.06 Lakhs in profit after tax for the full year. This dual announcement of shareholder returns and international expansion signals a growth-oriented outlook.
Key Highlights
Recommended a final dividend of ₹0.60 per equity share of face value ₹10 each.
Approved the setup of a new step-down subsidiary in the Sultanate of Oman to drive international growth.
Foreign subsidiary reported annual revenue of ₹17,378.57 Lakhs and PAT of ₹1,274.06 Lakhs for FY26.
Audited consolidated financial results for Q4 and FY26 have been approved by the Board.
The group's share of profit from associates stood at ₹33.52 Lakhs for the full financial year.
👀 What to Watch
Investors should note the dividend yield based on current market price and monitor the progress of the Oman expansion as a key driver for future international revenue.
Fabtech Technologies Recommends ₹0.60 Dividend and Announces Expansion into Oman
Fabtech Technologies has approved its audited financial results for the fiscal year ended March 31, 2026, and recommended a final dividend of ₹0.60 per share. The company is actively pursuing international growth by authorizing the opening of a new step-down subsidiary in the Sultanate of Oman. Financial disclosures reveal that its existing foreign subsidiary is a significant contributor, generating ₹17,378.57 Lakhs in revenue and ₹1,274.06 Lakhs in net profit for the full year. This expansion and dividend payout signal management's confidence in the company's global scaling capabilities and financial health.
Key Highlights
Recommended a final dividend of ₹0.60 per equity share of face value ₹10 for FY 2025-26.
Authorized the establishment of a new step-down subsidiary in the Sultanate of Oman to expand global operations.
Existing foreign subsidiary reported annual revenue of ₹17,378.57 Lakhs and net profit of ₹1,274.06 Lakhs.
Consolidated assets of the foreign subsidiary reached ₹15,589.55 Lakhs as of March 31, 2026.
The Board meeting concluded after a lengthy session from 1:30 p.m. to 8:45 p.m. to finalize annual results.
👀 What to Watch
Investors should view the Oman expansion as a positive growth catalyst for international revenue. The dividend provides a steady return, but the primary focus should remain on the execution of the new subsidiary's operations.
Fabtech Tech FY26 Results: ₹0.60 Dividend Declared and Expansion into Oman Approved
Fabtech Technologies Limited has reported its audited financial results for the fiscal year ending March 31, 2026, alongside a dividend announcement. The Board has recommended a final dividend of ₹0.60 per equity share, pending shareholder approval. Strategically, the company is expanding its global footprint by authorizing the opening of a step-down subsidiary in the Sultanate of Oman. Financial data indicates strong performance from international operations, with a foreign subsidiary contributing ₹173.78 crore to annual revenue and ₹12.74 crore to net profit.
Key Highlights
Recommended a final dividend of ₹0.60 per equity share (6% of face value) for FY 2025-26.
Approved the establishment of a new step-down subsidiary in the Sultanate of Oman to drive international growth.
Foreign subsidiary reported annual revenue of ₹17,378.57 Lakhs and a net profit of ₹1,274.06 Lakhs.
Foreign subsidiary assets reached ₹15,589.55 Lakhs as of March 31, 2026.
Consolidated results include a share of profit from associates amounting to ₹33.52 Lakhs for the full year.
👀 What to Watch
Investors should view the Oman expansion as a positive long-term growth driver for the company's international business. The dividend provides immediate value, but the focus should remain on the successful integration and scaling of the new Middle Eastern subsidiary.
Fabtech Technologies to Carry Forward Unutilized IPO Proceeds to FY 2026-27
Fabtech Technologies has announced that its board approved the carry-forward of unutilized IPO proceeds from the current financial year 2025-26 to FY 2026-27. The company confirmed that there has been no deviation in the utilization of funds from the objects stated in its prospectus dated October 02, 2025. This indicates a delay in the planned capital expenditure or project execution timeline originally envisioned for the current fiscal year. The funds remain earmarked for their original purposes in compliance with SEBI regulations.
Key Highlights
Board approved carry-forward of IPO proceeds from FY 2025-26 to FY 2026-27.
Confirmed zero deviation in fund utilization compared to the prospectus dated October 02, 2025.
Unutilized funds are strictly intended for objects stated in the original IPO filing.
The board meeting concluded at 12:45 p.m. on March 24, 2026.
👀 What to Watch
Investors should monitor the company's project execution pace, as the delay in fund utilization may push back the expected return on investment from IPO-funded projects. Check for updates in the next few quarters to ensure the capital is deployed effectively for growth.
Fabtech Technologies Reports ₹926 Cr Order Book and Targets $140B Pharma Infra Market
Fabtech Technologies has disclosed a robust order book of ₹926 crore as of January 31, 2026, positioning itself for a 15-year growth cycle in life sciences infrastructure. The company is targeting a massive total addressable market of USD 115-140 billion across the GCC, Maghreb, and Africa regions through 2040. With a strategic focus on medicinal sovereignty, Fabtech aims to double its project conversion rate from 10% to 20% following a recent European acquisition. The firm leverages its experience of over 2,000 projects across 62 countries to provide end-to-end turnkey solutions for pharma and biotech facilities.
Key Highlights
Confirmed order book stands at approximately ₹926 crore as of January 31, 2026
Identified a total addressable pharma infrastructure market of USD 115-140 billion through 2040
Targeting a doubling of the project conversion rate from 10% to 20% to drive structural growth
Extensive global footprint with over 2,000 projects completed across 62+ countries
Strategic focus on high-barrier segments including oncology, biosimilars, and vaccine facilities
👀 What to Watch
Investors should monitor the company's ability to convert its ₹926 crore order book into revenue and track the progress of the 20% conversion rate target. The long-term structural demand for pharma infrastructure in emerging markets provides a significant growth runway.
Fabtech Technologies Bags ₹63.6 Crore International Order for OSD Facility in West Africa
Fabtech Technologies Limited has secured a significant international contract valued at USD 7.05 million (approximately ₹63.6 crores) from a client in West Africa. The project involves the supply, installation, and commissioning of infrastructure for an Oral Solid Dosage (OSD) facility. The execution timeline is set for 23 to 27 months starting from the receipt of the advance payment. This order strengthens the company's international presence and provides clear revenue visibility for the next two years.
Key Highlights
Total order value of USD 7.05 million, equivalent to approximately ₹63.6 crores.
Project scope includes the supply, installation, and commissioning of an Oral Solid Dosage (OSD) facility.
Execution period is defined as 23-27 months from the date of receiving the advance payment.
The contract is with an international entity in West Africa, enhancing the company's global footprint.
👀 What to Watch
Investors should view this as a positive development for revenue growth; however, they should monitor the timely receipt of the advance payment which triggers the project timeline.
Fabtech Technologies Q3 FY26 Call: Order Book at ₹926 Cr, ₹20.3 Cr Revenue Deferred to Q4
Fabtech Technologies reported temporary softness in Q3 FY26 revenue due to shipment-based accounting, with ₹20.3 crores of revenue deferred to Q4 after material was held at the port. The company maintains a robust outstanding order book of ₹926 crores as of January 31, 2026, primarily driven by export demand in Africa and the Middle East. Management highlighted a significant 'hot lead bank' pipeline valued at approximately $455 million. The company is also streamlining its portfolio by exiting TSA Process Equipments within the current financial year to focus on its core life-sciences infrastructure platform.
Key Highlights
Outstanding order book reached ₹926 crores as of January 31, 2026, with a heavy focus on international markets.
Revenue of ₹20.3 crores was deferred from Q3 to Q4 due to timing of shipments and port delays.
Management identified a robust pipeline of potential orders (hot lead bank) worth approximately $455 million.
Company plans to exit its investment in TSA Process Equipments within the 2025-26 financial year.
Typical project execution timelines range from 9 to 18 months, with efforts underway to accelerate delivery.
👀 What to Watch
Investors should monitor Q4 FY26 results to confirm the realization of deferred revenues and the conversion of the $455 million pipeline into firm orders. While quarterly volatility is expected due to shipment-based billing, the strong order book provides healthy medium-term revenue visibility.
Fabtech Technologies 9M FY26 Revenue Rises 33% to ₹263 Cr; Net Profit Declines 48%
Fabtech Technologies reported a strong 32.79% YoY growth in total income to ₹26,309.11 Lakhs for 9M FY26. However, the company experienced a significant contraction in profitability, with EBITDA falling 45.04% and Net Profit dropping 48.02% to ₹1,630.23 Lakhs. EBITDA margins saw a sharp decline from 21.95% to 9.08%, indicating operational cost pressures. Despite the profit dip, the company maintains a robust order book of ₹98,305 Lakhs and holds ₹20,679 Lakhs in unutilized IPO proceeds for expansion.
Key Highlights
Total Income increased by 32.79% YoY to ₹26,309.11 Lakhs for the nine months ended December 2025.
Net Profit declined by 48.02% YoY to ₹1,630.23 Lakhs, with Net Profit Margin shrinking to 6.20%.
EBITDA margins contracted significantly to 9.08% from 21.95% in the previous year.
Order book remains strong at ₹98,305 Lakhs as of November 03, 2025.
Unutilized IPO proceeds of ₹20,679.40 Lakhs are available for working capital and inorganic growth initiatives.
👀 What to Watch
Investors should exercise caution due to the severe margin compression and seek clarity on the rising cost structure despite revenue growth. Monitor the execution of the ₹983 crore order book and the utilization of IPO proceeds for inorganic growth.
Fabtech Technologies Reports Q3 Loss of ₹5.68 Cr; Revenue Drops 40% YoY
Fabtech Technologies reported a weak Q3 FY26 with a consolidated net loss of ₹5.68 crore, a sharp reversal from the ₹20.46 crore profit in the same quarter last year. Revenue from operations declined significantly to ₹62.76 crore from ₹104.32 crore YoY, reflecting a 39.8% drop. While nine-month revenue grew to ₹252.25 crore, the net profit for the same period nearly halved to ₹16.30 crore due to rising finance and operating costs. The company also dissolved its Risk Management Committee, citing it is no longer mandatorily required under SEBI regulations.
Key Highlights
Consolidated Revenue for Q3 FY26 fell 39.8% YoY to ₹62.76 crore compared to ₹104.32 crore.
Reported a Net Loss of ₹5.68 crore in Q3 FY26 versus a Net Profit of ₹20.46 crore in Q3 FY25.
9M FY26 Net Profit declined by 48% to ₹16.30 crore despite a 31.5% increase in 9M revenue.
Finance costs for the nine-month period surged to ₹3.28 crore from ₹1.01 crore YoY.
Board approved the dissolution of the Risk Management Committee, with oversight moving to the Audit Committee.
👀 What to Watch
The sudden shift to a quarterly loss and significant revenue decline are major red flags; investors should exercise caution. It is advisable to wait for management's explanation regarding the margin compression and rising finance costs before considering further investment.
Fabtech Technologies Reports Q3 Loss of ₹5.68 Cr; Revenue Declines 40% YoY
Fabtech Technologies reported a weak performance for Q3 FY26, swinging to a consolidated net loss of ₹5.68 crore from a profit of ₹20.46 crore in the same period last year. Revenue from operations saw a sharp decline of 39.8% YoY to ₹62.76 crore, while sequential revenue dropped by nearly 48% compared to Q2 FY26. The results were significantly impacted by a loss of ₹5.86 crore in its UAE-based foreign subsidiary. Despite a 31.5% revenue growth for the nine-month period ending December 2025, net profit for the same period nearly halved to ₹16.30 crore.
Key Highlights
Consolidated revenue for Q3 FY26 fell to ₹62.76 crore from ₹104.32 crore in Q3 FY25.
Reported a net loss of ₹5.68 crore in Q3 FY26 against a profit of ₹20.46 crore in the previous year's quarter.
UAE subsidiary (Fabtech Technologies LLC) dragged performance with a quarterly loss of ₹5.86 crore.
9M FY26 net profit declined to ₹16.30 crore from ₹31.36 crore in 9M FY25 despite higher cumulative revenue.
Board approved the dissolution of the Risk Management Committee, citing it is no longer mandatory under SEBI regulations.
👀 What to Watch
Investors should exercise caution as the company has moved from high profitability to a loss within a single quarter, indicating significant margin pressure and volatility in international operations. Monitor management's outlook on the UAE subsidiary and the reasons behind the sharp sequential revenue drop.
